ICAD vs. GLMD

Last updated Jun 3, 2026

ICAD (iCAD, Inc.) and GLMD (Galmed Pharmaceuticals Ltd.) are both stocks. Both are in the Healthcare sector — ICAD in Health Information Services, GLMD in Biotechnology. At a 0.14 correlation, their price movements are largely independent.

Performance

ICAD vs. GLMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iCAD, Inc. (ICAD) and Galmed Pharmaceuticals Ltd. (GLMD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ICAD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

GLMD

• 1D: -4.96%
• 1M: 21.01%
• YTD: -7.91%
• 6M: -27.93%
• 1Y: -52.34%
• 3Y*: -77.01%
• 5Y*: -73.13%
• 10Y*: -50.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ICAD vs. GLMD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ICAD iCAD, Inc.	0.00%	111.48%	3.39%	-3.28%	-74.58%	-45.45%	69.88%	110.00%	7.56%	6.34%
GLMD Galmed Pharmaceuticals Ltd.	-7.91%	-76.47%	-41.58%	-93.93%	-72.53%	-41.48%	-46.19%	-15.37%	-25.36%	160.68%

Correlation

The correlation between ICAD and GLMD is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.15
Correlation (All Time) Calculated using the full available price history since Mar 14, 2014	0.14

Fundamentals

Total Revenue (TTM) ICAD : $19.53M GLMD : $0.00
Gross Profit (TTM) ICAD : $16.77M GLMD : $0.00
EBITDA (TTM) ICAD : -$4.84M GLMD : -$8.49M

Return for Risk

ICAD vs. GLMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLMD

GLMD Risk / Return Rank: 17
GLMD Sharpe Ratio Rank: 14
GLMD Sortino Ratio Rank: 17
GLMD Omega Ratio Rank: 18
GLMD Calmar Ratio Rank: 17
GLMD Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ICAD vs. GLMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iCAD, Inc. (ICAD) and Galmed Pharmaceuticals Ltd. (GLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ICAD	GLMD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.61	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.44	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.37	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.38	—

Drawdowns

Drawdown Indicators

	ICAD	GLMD	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.99%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-79.62%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-99.16%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-99.93%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.99%	—
Current Drawdown Current decline from peak	—	-99.98%	—
Average Drawdown Average peak-to-trough decline	—	-74.34%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	55.31%	—

Volatility

Volatility by Period

	ICAD	GLMD	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	25.26%	—
Volatility (6M) Calculated over the trailing 6-month period	—	62.71%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	86.30%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	166.32%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	137.60%	—

Dividends

ICAD vs. GLMD - Dividend Comparison

Neither ICAD nor GLMD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ICAD and GLMD in my portfolio?

ICAD and GLMD have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.